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Abstract The use of skin allografts to temporarily
replace lost or damaged skin is practiced worldwide.
Naturally occurring contamination can be present on
skin or can be introduced at recovery or during
processing. This contamination can pose a threat to
allograft recipients. Bacterial culture and disinfec-
tion of allografts are mandated, but the specific
practices and methodologies are not dictated by
standards. A systematic review of literature from
three databases found 12 research articles that eval-
uated bioburden reduction processes of skin grafts.
The use of broad spectrum antibiotics and antifungal
agents was the most frequently identified disinfection
method reported demonstrating reductions in contam-
ination rates. It was determined that the greatest
reduction in the skin allograft contamination rates
utilized 0.1 % peracetic acid or 25 kGy of gamma
irradiation at lower temperatures.
Keywords Skin allografts  Tissue donation  Tissue
banking  Bioburden  Skin decontamination
Introduction
Skin banking is a process in which skin grafts are
recovered from a cadaveric donor and stored (banked)
for future use. Health Canada’s definition of
‘‘banked’’, with respect to cells and tissues, are
processed cells and tissues that have been determined
safe for transplantation, and are stored by the source
establishment in its inventory and are available for
distribution or transplantation (Government of Canada
2013). The contamination rate represents the
Electronic supplementary material The online version of
this article (doi:10.1007/s10561-016-9569-2) contains supple-
mentary material, which is available to authorized users.
C. Johnston
Capital Health Regional Tissue Bank, 5788 University
Avenue, Room 431 Mackenzie Building, Halifax,
NS B3H 1V7, Canada
J. Callum
Sunnybrook Health Sciences Centre Blood and Tissue
Bank, 2075 Bayview Ave., Room B2 04, Toronto,
ON M4N 3M5, Canada
J. Mohr
Canadian Blood Services, 270 John Savage Ave.,
Dartmouth, NS B3B 0H7, Canada
A. Duong  A. Garibaldi  N. Simunovic  O. R. Ayeni
Department of Surgery, McMaster University, 293
Wellington St. N, Suite 110, Hamilton, ON L8L 8E7,
Canada
O. R. Ayeni (&)
McMaster University Medical Centre, 1200 Main St W,
Room 4E15, Hamilton, ON L8N 3Z5, Canada
e-mail: Ayenif@mcmaster.ca
123
Cell Tissue Bank (2016) 17:585–592
DOI 10.1007/s10561-016-9569-2
proportion of tissues with bacterial or fungal contam-
ination at different points during graft processing, and
the bioburden denotes the quantity of organisms in
each sample. Bioburden reduction (disinfection) is
defined as a process or intervention applied to skin
grafts following recovery, which reduces bacteria and/
or fungal bioburden. Reduction due to antimicrobial
intervention can be assessed qualitatively in relation to
changes in contamination rate or quantitatively by
accurately determining the bioburden load before and
after an intervention. Assessment of the effects of
bioburden reduction processes on tissue viability and
structural integrity are also critical for patient
outcomes.
With the establishment of a number of tissue banks
worldwide, there have been an increasing number of
different practices reported for tissue disinfection.
Increasing the storage period of skin is known to
increase the probability of contamination (Gala et al.
1997). To reduce this, tissue banks strive to (1)
minimize bioburden, (2) eliminate virulent organisms,
and (3) maintain cell viability to contribute to optimal
patient outcomes.
Methods
Information sources and search
The search strategy was developed by the Skin
Processing and Validation Subgroup (through JM)
and an information specialist. The search was applied
to electronic databases MEDLINE and EMBASE
from 1988 to July 7, 2014 using the following
headings and text words: ‘‘skin,’’ ‘‘derm*,’’ ‘‘der-
matoplast,’’ ‘‘allograft,’’ ‘‘anti-bacterial,’’ ‘‘anti-fun-
gal,’’ ‘‘sterilization,’’ and ‘‘tissue banking’’. The
search included publications in English and excluded
animal studies, case reports and conference abstracts.
Two additional reviewers (AG and AD) performed a
second search using the original search strategy to
include publications from July 7, 2014 up to March 6,
2015. The full search strategy is shown in Online
Resource 1.
Study selection
Four reviewers (JM, SM, CP, PG) independently
screened each of the citations in duplicate to identify
studies that met all of the following inclusion criteria:
(1) evaluated human skin (2) evaluated a method to
reduce contamination rates, and (3) evaluated biobur-
den as an outcome. A study was excluded if it was a
case report, editorial, letter, or review. If there was
disagreement, the full report was retrieved and an
independent assessment was repeated until consensus
was reached.
Data abstraction
The design of data abstraction forms and evidence
tables were guided by the questions in the analytic
framework (Online Resource 2) and approved and
finalized by the Skin Bioburden Reduction working
group at Canadian Blood Services (through JM). Two
reviewers (AG and AD) independently collected data
for the following study characteristics: first author,
year of publication, country, sample size, donor type,
recovery site, tissues collected, pre-recovery skin
disinfection method, post-recovery storage parame-
ters and preservation methods. The bioburden testing
method was summarized for each study. Data col-
lected relating to the outcomes included: microbes
detected immediately following tissue recovery,
bioburden immediately following tissue recovery
and disinfection, antimicrobial intervention following
bioburden assessment, incubation parameters, tissue
integrity, and the proportion of allografts discarded
due to contamination.
Quality assessment
There were no clinical studies found among the final
pool of included articles. There is no validated quality
assessment tool for laboratory-based studies, such as
Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) (Guyatt et al. 2011).
Basic science research is inherently considered level
IV, or low quality evidence (Balshem et al. 2011).
Data analysis
Data abstracted from all included studies were orga-
nized into tables presenting study characteristics,
culture methods, and outcomes. Descriptive statistics
included the bioburden outcome, the proportion of
discarded allografts, and the logarithmic reduction of
bioburden. Proportions, means, ranges, and measures
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of variance such as standard deviations (SD) are
presented when available. In laboratory studies, the
tissue discard rate is synonymous with the contami-
nation rate. All analyses of these values were
performed as one cohort when appropriate.
Results
Study selection
A total of 3774 citations were reviewed after dupli-
cates were removed (Fig. 1). Of the 3774 records,
3733 were excluded because they did not fulfill the
eligibility criteria. The full text-articles of the remain-
ing 41 citations were retrieved for further evaluation.
Twenty-nine studies were excluded for varying rea-
sons as listed in Online Resource 3. Four additional
citations were added that were identified by searches
of the reference lists of the included articles. Follow-
ing the updated search (2014–2015), an additional 148
articles were reviewed, and 2 were identified for
further evaluation. Both articles were excluded due to
the lack of meeting the bioburden outcome criteria.
Overall, twelve papers met the inclusion criteria.
Characteristics and culture methods of the studies
All 12 studies were observational and were conducted
from 1994 to 2012, with the majority in Europe
(58.3 %, 7/12; Table 1). Studies were all single-
centered laboratory reports. Six studies were prospec-
tive (Baldeschi et al. 1998; Kairiyama et al. 2009;
Lomas et al. 2003; Rooney et al. 2008; van Baare et al.
1998; White et al. 1991) and six were retrospective in
design (Ireland and Spelman 2005; Lindford et al.
2010; Mathur et al. 2009; Neely et al. 2008; Pianigiani
et al. 2010; Pirnay et al. 2012).
A total of 2965 donors, and 2575 allografts/
homografts and skin samples were reported in twelve
studies. In seven studies, skin samples were harvested
from cadaveric human donors. In other studies,
samples were harvested from a combination of
cadaveric, organ, and living donors (Pianigiani et al.
2010), or were harvested solely from organ donors
(Lindford et al. 2010). Prior to sample procurement,
shaving of the area was performed in three studies
before rinsing and cleaning with a variety of agents,
including 7.5 % polyvidone-iodine soap, 0.5 %
(weight/volume, w/v) chlorhexidine with 70 % iso-
propanol solution, betadine scrub, or Dodosep (Online
Resource 4). The presence of microorganisms was
confirmed by culturing of bacterial or fungal species
(Online Resource 5). Ten studies reported that 75.0 %
(1931/2575) of allograft samples were eligible for
release and/or were culture negative for microbial
contamination prior to additional disinfection (Balde-
schi et al. 1998; Ireland and Spelman 2005; Lindford
et al. 2010; Mathur et al. 2009; Neely et al. 2008;
Pianigiani et al. 2006; Pirnay et al. 2012; Rooney et al.
2008; van Baare et al. 1998; White et al. 1991).
Following procurement, skin grafts were stored in
cold phosphate buffer saline (PBS) at 2–10 C and pH
7.2–7.3 for 24–72 h (Lomas et al. 2003; Pianigiani
et al. 2010; Pirnay et al. 2012; Rooney et al. 2008).
Prior to long-term storage, samples were preserved
using cryopreservation at-80 to-135 C, or through
glycerol preservation.
An antimicrobial intervention was included in all
12 studies to reduce contamination of the allograft by
harmful pathogens. Interventions included incubation
with antibiotic/antifungal agents (containing peni-
cillin, streptomycin, amphotericin B, gentamicin,
imipenem, polymyxin B, vancomycin, nystatin, ami-
kacin, or ceftazimidine), irradiation, or incubation
with peracetic acid (PAA) or glycerol (Online
Resource 6).
Study outcomes
Contamination rate and microbe identification
Prior to processing/disinfection of tissues, the con-
tamination rate ranged from 10.1 to 95 % of the
allograft samples containing one or more positive
result for microorganisms (mean 37.2 %, SD 32.3 %).
Ten studies cleaned and disinfected the skin tissue
prior to recovery of the allograft. No difference in the
contamination rate was observed between disinfection
agents.
The most common microorganisms observed fol-
lowing tissue recovery were Staphylococcus and
Propionibacterium species (commensal skin flora).
Other organisms cultured from the allografts included
Acinetobacteria, Streptococcus epidermidis, Micro-
coccus, Candida albicans, Bacillus spp., and Escher-
ichia coli.
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Contamination rate reduction
The greatest reduction in contamination and allo-
graft discard rate with regards to antibiotic treat-
ments occurred when the allografts were incubated
with three different combinations of antibiotics: (1)
penicillin (100 U/ml), streptomycin (100 units (U)/
ml), and amphotericin B (1.25 lg/ml) (Pirnay et al.
2012); (2) penicillin (100 U/ml) and streptomycin
(100 U/ml) in 85 % glycerol (Pianigiani et al.
2010); and (3) penicillin, streptomycin, kanamycin,
gentamicin, and nystatin (Neely et al. 2008). These
antibiotic combinations resulted in the greatest
reduction of the allograft discard rate (1.4, 1.2 and
0 %, respectively). The tissue discard rate was 0 %
in one study despite identifying a positive culture
rate of 6.8 % of tissues following disinfec-
tion (Neely et al. 2008). The use of streptomycin
and penicillin with glycerol or cryopreservation
were effective in reducing the initial disinfection
rate from an average of 29.6–9.6 % among five
studies. In the studies that used antibiotics to
disinfect tissues, the allograft discard rate ranged
from 2.8 to 35 %. Incubation times ranged from 3 h
to 4 weeks at temperatures between 2 and 38 C.
The addition of amphotericin B (a fungicide) to the
penicillin and streptomycin antibiotic mixture
reduced the contamination rate to only 47.4 % in
one study (Pirnay et al. 2012).
In addition to antibiotics, other studies used radi-
ation or chemical agents for allograft disinfection. The
use of radiation demonstrated 100 % disinfection of
bacterial monoculture after exposure to an average of
25 kGy (Kairiyama et al. 2009). Irradiation of samples
at ambient versus frozen temperatures showed no
difference in effectiveness, and were able to achieve
a[ 8 fold log reduction in bioburden with 25 kGy
irradiation treatment in 20 and 50 % glycerol solutions
(Rooney et al. 2008). In another study, treatment of
samples with PAA (0.1 %) demonstrated 100 %
disinfection in all samples after a 90 min incubation
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Fig. 1 Screening process flow diagram
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Tissue integrity
Two studies performed tissue integrity tests on
allografts exposed to different disinfection methods
(Lomas et al. 2003; Rooney et al. 2008). Tissue
integrity (intact epidermis, papillary and retdicular
dermis) was maintained after irradiation when sam-
ples were stored in either 20 of 50 % glycerol in PBS
(v/v) (Rooney et al. 2008). Processing of tissues in
0.1 % PAA did not affect tissue integrity whereas
grafts treated with PAA and preserved in propylene
glycol were at risk for collagenase digestion compared
to untreated controls (Lomas et al. 2003). Tissue
integrity tests following antibiotic treatments were not
reported in any of the remaining studies.
Confounding factors
The addition of antibiotics and other disinfection
methods decrease the contamination and allograft
discard rate, but there is little consensus as to the
combination, type and concentration of antibiotics
used, as well as the optimal solutions to protect tissue
undergoing irradiation. For example, in conjunction
with other antibiotics, the quantity of penicillin added
ranged from 100 to 1000 U/ml and from 1 to 30 lg/
ml. The incubation environment during the antibiotic
treatment varied greatly. Incubation temperatures
ranged from 2 to 38 C, whereas the incubation period
was as short as 3 h, and extended up to 4 weeks.
Discussion
In this review, contamination of tissues following
recovery was found to be quite variable despite
attempts to reduce bioburden prior to recovery,
such as the method used to disinfect the skin.
Processes to disinfect tissues with a combination of
antibiotics and antifungals, irradiation or PAA
treatment were found to be effective in reducing
positive culture results and have minimal, if any
effect on tissue integrity. Preservation of samples
with 10 or 20 % glycerol compared to other
methods of cryopreservation was shown to have
an antimicrobial effect.
Table 1 Study characteristics
References Country Sample size Donora Recovery site Tissues
Pirnay et al. (2012) Belgium 148 Donors Cadaveric Operating theatre or
autopsy room
Skin allografts
Lindford et al. (2010) Netherlands 115 Donors Organ Operating theatre Skin allografts
Pianigiani et al.
(2010)
Italy 723 Donors Cadaveric organ
living
Operating theatre Skin allografts
Kairiyama et al.
(2009)
Argentina 106 Skin batches Cadaveric NR Skin allografts
Mathur et al. (2009) India 30 Skin grafts Cadaveric NR Skin allografts
Neely et al. (2008) USA 114 Skin grafts NR Operating room Skin allografts
Rooney et al. (2008) UK 3 Donors NR NR Skin allografts
Ireland and Spelman
(2005)





Lomas et al. (2003) UK 4 Donors Cadaveric NR Skin allografts
Baldeschi et al. (1998) UK 40 Skin grafts NR NR Skin allograft
(eyelid)
van Baare et al. (1998) Netherlands 1929 Donors Cadaveric Autopsy room Skin allograft
White et al. (1991) USA 182 Samples from 19
donors
Cadaveric Autopsy room Skin allografts
NR not reported
a Samples were recovered from cadavers (tissue donor), organ (organ and tissue) or from living patients
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Following recovery of the skin allografts, it was
found that between 10.1 and 95 % of the allografts
were culture positive. When reported, different meth-
ods of pre-recovery skin preparation did not appear to
reduce the contamination rate. All 12 studies disin-
fected all samples/allografts, regardless of the level of
contamination. Among all studies, the average con-
tamination rate was reduced from 37.2 to 15.3 %
positive tissue following intervention.
The most common disinfection strategy to reduce
the bioburden in studies was a combination of broad
spectrum antibiotics with antifungal agents. In three
studies, the tissue discard rate was reduced to an
average of 19.1 % when penicillin and streptomycin
were used in conjunction with the antifungal agent,
amphotericin B or nystatin (Pianigiani et al. 2010;
Pirnay et al. 2012; White et al. 1991). The presence of
the fungus, Candida, was observed in the initial
bioburden following tissue recovery in five studies,
suggesting their relatively consistent prevalence in
skin allografts and the potential need to address these
contaminating fungi when choosing a disinfection
procedure (Baldeschi et al. 1998; Ireland and Spelman
2005;Mathur et al. 2009; Pianigiani et al. 2010; Pirnay
et al. 2012). The clinical use of antibiotics and
antifungals clinically to treat infections attests to their
relative safety when being applied to tissue in relation
to cellular integrity. However, tissue integrity was not
assessed in any of these studies.
The studies differed in the concentration of antibi-
otics used (when reported), as well as the incubation
duration and temperature at which disinfection
occurred. Minimal differences in bioburden reduction
were observed with varying concentrations of antibi-
otics, but it was found that incubation of the tissue with
antibiotics at a temperature of 37 C for 3 h was
effective in reducing the number of positive cultures to
13.7 % (ranging from 0 to 27.4 %) in two studies
(Ireland and Spelman 2005; Lindford et al. 2010).
Generally, antibiotic activities are greatest at 38 C,
and decrease with temperature (Lindford et al. 2010).
Most studies chose to use a lower temperature for an
extended period of time (up to 4 weeks) to inhibit
bacterial growth. Incubation of tissues in the antibi-
otic-containing solution at 4 C for 4 weeks reduced
the contamination rate from 26.6 to 1.24 % in one
study (Pianigiani et al. 2010). Interestingly, incubation
at the same temperature for an intermediate period of
1–6 days showed a higher proportion of samples with
positive culture, averaging 23.2 % (Baldeschi et al.
1998; Lomas et al. 2003; Mathur et al. 2009; Pirnay
et al. 2012; White et al. 1991).
One study utilized PAA to disinfect the allografts.
Lomas et al. (2003) treated the tissues with 0.1 % PAA
and were able to achieve 100 % reduction in contam-
ination rate following a 90 min incubation, with no
observable impact on tissue integrity (Lomas et al.
2003). PAA is advantageous in that it readily kills
almost all bacteria, including spores. Its breakdown
products (oxygen and acetic acid) are harmless to
humans, and it can be effectively used to cold-sterilize
temperature sensitive equipment and tissues that are
not amenable to heat sterilization or incubation at high
temperatures (Lomas et al. 2003).
Irradiation was evaluated in two studies and found
that 25 kGy is sufficient for disinfection of skin
allografts (Kairiyama et al. 2009; Rooney et al. 2008).
An up to 5.2-fold logarithmic reduction (complete
disinfection) in bioburden was observed after expo-
sure to up to 33.4 kGy (Kairiyama et al. 2009). The
authors note that establishment of a standard irradia-
tion level (such as 25 kGy seen in Rooney et al. 2008),
will require a method to reduce the bioburden to
acceptable levels (number of microorganisms in the
allograft are lower than the logarithmic reduction
potential of the disinfection method) prior to irradia-
tion. The sterility assurance level or the probability of
a contaminating microorganism following disinfec-
tion is extremely dependent on the initial bioburden
(Rooney et al. 2008). In other reported studies,
irradiation may reduce tissue integrity at higher doses,
but irradiation of the tissues while stored in 20 %
glycerol solutions provides a protective effect, greatly
reducing the incidence of tissue damage (Rooney et al.
2008).
Tissue banks worldwide use cryopreservation
(storage at \-150 C) to maintain tissue integrity
over long periods. High concentrations (70–85 %) of
glycerol have been reported to be bactericidal (Lind-
ford et al. 2010). When penicillin and streptomycin
were solely used to disinfect allografts, the average
proportion of positive cultures was 22 % (Ireland and
Spelman 2005; Mathur et al. 2009). In other studies,
the addition of glycerol preservation to the penicillin
and streptomycin treatment reduced the average
contamination rate to 0.4 % (Lindford et al. 2010;
Pianigiani et al. 2010; van Baare et al. 1998). The
addition of glycerol to antibiotic treatment appears to
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greatly reduce the incidence of contamination. How-
ever, the suitability of glycerol preservation for long
term storage, or the financial implications of this
technique were not reported in these studies (Lindford
et al. 2010; Pianigiani et al. 2010; van Baare et al.
1998).
Limitations
Integrity of the allografts following disinfection was
reported in only two articles, but is extremely impor-
tant for a successful allograft. In addition, transplan-
tation outcomes were not reported in any of these
studies.
The contamination rate was determined using
standard microbiological culturing techniques on a
variety of different culture media and conditions.
Although this is the standard practice among labs
worldwide, the choice of medium and incubation
conditions are extremely important, as many bacteria
and fungi can only grow within a very limited set of
conditions. A sensitive assay to culture all organisms
(or at least pathogenic organisms) is extremely
important in reducing the incidence of transplanta-
tion-associated infections. The study methods were
highly variable, and the optimal method of bacterial
identification is not known.
The identification of the bacterial and fungal
species is also equally important. Of the identified
organisms in these reports, many of these species
would not be considered pathogenic. However,
patients receiving allografts may be immunocompro-
mised, and the impact of contamination with normal
skin flora is unknown. The classification of
pathogenicity is relative, and will determine the
suitability for the allograft to be released for trans-
plantation. In these laboratory studies, all tissues with
contaminating microorganisms (positive culture)
would hypothetically be discarded and not used as
allografts. Interestingly, Neely et al. (2008) suggested
that all of their allografts could be released for
transplantation, despite 6.8 % of allografts having a
positive culture result. They noted that all contami-
nating organisms were part of normal skin flora, but
quantification of the bioburden was not performed.
Evaluation of the effectiveness of the antimicrobial
intervention was performed in this review. The
majority of the articles presented the disinfection rate
as a proportion of allografts discarded due to contam-
ination or potentially rejected due to positive culture
following disinfection. Although this was an effective
metric in terms of quality assessments of the antibi-
otics’ effectiveness in reducing the entire population
of microorganisms, a more quantitative method of
bioburden would allow for more accurate and opti-
mized recommendations. In this review, the bioburden
or bacterial load was only reported in three articles
(Lomas et al. 2003; Pirnay et al. 2012; Rooney et al.
2008). The reduction in bioburden provides the
greatest wealth of information regarding the effec-
tiveness of the antimicrobial treatment, as the effects
of the intervention are easily quantified. Therefore, the
majority of the recommendations in this review are
based on the reduced rate of contamination (propor-
tion of allograft samples that are culture positive
following disinfection).
Conclusion
The results of this systematic review found that the
use of broad spectrum antibiotics in conjunction
with antifungal agents, at low temperatures, disin-
fection with 0.1 % PAA, or with 25 kGy of gamma
irradiation results in a reduction of the tissue
contamination rate, as opposed to the use of broad
spectrum antibiotics alone. Disinfection of the skin
prior to recovery is presumed to be important, but
the use of common cleansers such a chlorhexidine,
povidone-iodine, and Dodesept all appear to have
similar efficacies in reducing bioburden following
tissue recovery. Given that the studies in this review
did not test the efficacies of antimicrobial interven-
tions relative to one another, and are mostly
relegated to laboratory studies (where transplanta-
tion of the treated tissues is not performed and
evaluated for its clinical effectiveness), these out-
comes should be interpreted with caution.
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